New CAR-T therapy trial offers hope for Tough-to-Treat lymphoma
Disease control
Not yet recruiting
This study is testing an experimental treatment called TC011, a type of CAR-T cell therapy, in adults whose follicular lymphoma has returned or hasn't responded to at least two prior treatments. The goal is to see if this one-time infusion of a patient's own modified immune cells…
Phase: PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC